AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -99.9% | 1,608 | -99.5% | 0.00% | -100.0% |
| Q4 2021 | $709,000 | -32.0% | 356,208 | -1.7% | 0.01% | -16.7% |
| Q3 2021 | $1,043,000 | -24.0% | 362,208 | 0.0% | 0.01% | -33.3% |
| Q2 2021 | $1,373,000 | +18.6% | 362,208 | +5.8% | 0.01% | +28.6% |
| Q1 2021 | $1,158,000 | +20.9% | 342,208 | 0.0% | 0.01% | +16.7% |
| Q4 2020 | $958,000 | +5887.5% | 342,208 | +5368.3% | 0.01% | – |
| Q3 2020 | $16,000 | -27.3% | 6,258 | +289.2% | 0.00% | – |
| Q2 2020 | $22,000 | +144.4% | 1,608 | +30.9% | 0.00% | – |
| Q1 2020 | $9,000 | +12.5% | 1,228 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | +60.0% | 1,228 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | +150.0% | 1,228 | +224.9% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 378 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 378 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | – | 378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |